𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation

✍ Scribed by Christophe Hézode; Christophe Duvoux; Georgios Germanidis; Françoise Roudot-Thoraval; Anne-Laure Vincens; Philippe Gaulard; Daniel Cherqui; Jean-Michel Pawlotsky; Daniel Dhumeaux

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
80 KB
Volume
30
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C virus infection and lymphopr
Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation
✍ Nizar N. Zein; Rogelio G. Perez; Russel H. Wiesner 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 1 views

with treatment failures moving on to combination therapy (IFN/CMB). The primary difference between the two best strategies (IFN/CBM vs. CMB-G) was that the CMB-G strategy was more successful with those with genotype 1. Thus, the genotyping strategy reached more people with less responsive disease th

Recurrence of hepatitis C virus infectio
Recurrence of hepatitis C virus infection after orthotopic liver transplantation
✍ Paul Martin; Santiago J. Muñoz; Adrian M. Di Bisceglie; Raphael Rubin; Jeanne G. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 1 views

## Identification of the hepatitis C virus-the main cause of posttransfusion and sporadic non -A, non-B hepatitisand the development of a diagnostic serological test have allowed us to study possible recurrence of this type of hepatitis after liver transplantation. Six of 34 consecutive transplant

Early recurrence of hepatitis C virus in
Early recurrence of hepatitis C virus infection after liver transplantation
✍ Lydia M. Petrovic 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

1. Early recurrence of hepatitis C is universal. 2. Typical histopathologic features of hepatitis C virus (HCV) and acute allograft rejection (AAR) exist. 3. Early recurrent HCV may be differentiated from AAR. 4. Liver biopsy plays a role in diagnosing HCV and AAR. 5. Risk factors for recurrent HCV

Recurrent and new hepatitis C virus infe
Recurrent and new hepatitis C virus infection after liver transplantation
✍ James E. Everhart; Yuling Wei; Heather Eng; Michael R. Charlton; David H. Persin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

Chronic infection with the hepatitis C virus (HCV) is the most common reason for liver transplantation. We examined the results of laboratory tests for HCV on a cohort of patients who received a liver transplant between 1990 and 1994 at three large centers. Seven hundred twenty-two recipients and 60

Use of radiation therapy in posttranspla
Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation
✍ B.H. Koffman; A.S. Kennedy; M. Heyman; J. Colonna; C. Howell 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 328 KB 👁 2 views

## Posttransplant lymphoproliferative disorder (PTLD) is a common and lifethreatening complication of immunosuppression used to prevent rejection of solid organ and bone marrow transplants. There is no standardized treatment algorithm, but numerous management strategies are available. We describe a

Long-term outcome of hepatitis C virus i
Long-term outcome of hepatitis C virus infection after liver transplantation
✍ K. H. Böker; G. Dalley; M. J. Bahr; H. Maschek; H. L. Tillmann; C. Trautwein; K. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 1 views

Carrier states without significant laboratory abnormali-We analyzed the long-term clinical course of 71 paties are observed in approximately 16%, biochemical abtients with RNA-positive hepatitis C virus (HCV) infecnormalities without symptoms are seen in 60%, and tion after liver transplantation. Pa